# Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer

> **NCT03677076** · — · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 14 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Ancillary/Correlative

## Key facts

- **NCT ID:** NCT03677076
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-04
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03677076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03677076, "Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03677076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*